ライフサイエンスコーパス: stent-graft

1 body aortic stent grafts (Endologix AFX2 AAA stent graft).

2 unibody stent grafts (eg, Endologix AFX AAA stent grafts).

3 t with an endovascular bifurcated aortoiliac stent graft.

4 the implantation of a self-expanding nitinol stent graft.

5 astin-poor neointima incorporated the entire stent graft.

6 the proximal coronary artery with a covered stent graft.

7 or balloon angioplasty plus placement of the stent graft.

8 bdominal aortic aneurysm with an endoluminal stent graft.

9 e patients after placement of an aortobiliac stent-graft.

10 have undergone AAA exclusion with the AneuRx stent-graft.

11 ted in an endovascular suite with the AneuRx stent-graft.

12 red red and white blood cells adhered to the stent-graft.

13 air by means of placement of an endovascular stent-graft.

14 superior to that after TIPS with the nitinol stent-graft.

15 e same procedure by placing a second nitinol stent-graft.

16 o determine the long-term performance of the stent-graft.

17 rd the use of endovascular bifurcated aortic stent grafts.

18 r monitoring safety events related to aortic stent grafts.

19 successfully with two heparin-bonded covered stent grafts.

20 pproximation to the mechanical assessment of stent grafts.

21 owing treatment of aortoiliac aneurysms with stent-grafts.

22 nts prior to transfemoral delivery of aortic stent-grafts.

23 th prediction for 31 AneuRx and two Excluder stent-grafts.

24 ent of aortoiliac aneurysms with endoluminal stent-grafts.

25 t-graft that did not narrow the lumen of the stent-grafts.

26 rtic aneurysm were treated with endovascular stent-grafts.

27 tinol polytetrafluoroethylene (PTFE)-covered stent-grafts.

28 were successfully treated with endovascular stent grafting.

29 of thoracic aortic aneurysms by endovascular stent-grafting.

30 d higher absolute TL expansion at the distal stent-graft (5.9 +/- 3.1 vs. 3.3 +/- 5.4 mm; p = 0.036)

31 US centers preferentially used Zenith stent-grafts (54.2%) and European centers Endurant stent

32 grafts (54.2%) and European centers Endurant stent-grafts (62.2%) for the main body component.

33 omplications triggered the implantation of a stent graft (86.5%), mainly because of bleeding (90.6%)

34 CT) angiograms in 158 patients who underwent stent-graft AAA repair were retrospectively reviewed to

35 We studied the placement of endovascular stent-grafts across the primary entry tear for the manag

36 Placement of endovascular stent-grafts across the primary entry tears was technica

37 l assessment of the safety of unibody aortic stent grafts among Medicare beneficiaries.

38 evaluation are correct sizing of the aortic stent-graft and localization of the artery of Adamkiewic

39 ndromes, peripheral vascular disease, aortic stent-graft and transcatheter aortic valve assessment, a

40 lexible PTFE-encapsulated balloon-expandable stent-grafts and four control TIPS with bare Wallstents)

41 morphological changes and PDGF expression in stented grafts and contralateral unstented grafts in the

42 novel angioplasty balloons; nitinol stents, stent grafts, and drug-eluting stents; excisional, laser

43 egies for ASARVI include manual compression, stent grafts, and vascular surgery.

44 sfully excluded by implantation of a covered stent-graft, and 10 patients necessitated surgical inter

45 l proliferation were sustained in externally stented grafts, and these effects were associated with a

46 graft stents were placed in 11 patients, and stent-graft angioplasty alone was performed in one patie

47 Endovascular stent grafts are likely to be increasingly deployed, and

48 hort study evaluating whether unibody aortic stent grafts are noninferior to non-unibody aortic stent

49 rgical repair, and endoluminal deployment of stent-grafts are new developments that provide new optio

50 Of 87 163 patients who underwent aortic stent grafting at 2146 US hospitals, 11 903 (13.7%) rece

51 PTFE stent-grafts can markedly prolong TIPS patency, potentia

52 uction of endovascular aneurysm repair using stent grafts causing a major paradigm shift in the field

53 reatment for endoleak in eight patients, and stent-graft collapse or infolding in six patients.

54 ificantly higher with self-expanding covered stent grafts compared with bare-metal stents (10.6% vers

55 ontrast) and clear understanding of specific stent-graft components and placement.

56 primary unassisted patency in patients with stent-grafts confined to the parenchymal tract was 75% +

57 The type of stent-graft, contrast volume during the primary procedur

58 Current generation stent grafts correlated with significantly improved outc

59 The mean total hospital cost (including stent-graft costs and excluding attending physician fees

60 These initial results suggest that stent-graft coverage of the primary entry tear may be a

61 ing two procedures because of failure of the stent-graft delivery system.

62 The technical challenges of stent graft deployment in the descending thoracic aorta,

63 eratively and during the intervention before stent-graft deployment and relative hypertension after d

64 Following stent-graft deployment, helical CT data were analyzed fo

65 angiographers, who were not involved in the stent-graft deployment, interpreted the conventional ang

66 clopidogrel bolus was administered prior to stent-graft deployment.

67 the clopidogrel bolus was administered after stent-graft deployment.

68 ed with the aortoiliac arterial length after stent-graft deployment.

69 strategy can have a powerful effect in EVAR stent graft designing, as well as EVAR planning.

70 Stent graft devices for the treatment of abdominal aorti

71 tients underwent EVAR utilizing 10 different stent graft devices.

72 Patients received 1 of 12 different stent graft devices.

73 cular treatment of aortoiliac aneurysms with stent-graft devices may be an alternative to surgery.

74 of 16 patients who received a Dacron-covered stent-graft during revision or de novo creation of TIPS.

75 nal aortic aneurysms, in particular, unibody stent grafts (eg, Endologix AFX AAA stent grafts).

76 ease of the most contemporary unibody aortic stent grafts (Endologix AFX2 AAA stent graft).

77 On November 23, 1992, the first endovascular stent graft (ESG) repair of an aortic aneurysm was perfo

78 ct was 75% +/- 22, and that of patients with stent-grafts extending at least 1 cm into the portal vei

79 In the SAFE-AAA Study, unibody aortic stent grafts failed to meet noninferiority compared with

80 xpanded polytetrafluoroethylene endovascular stent graft for revision of venous anastomotic stenosis

81 ed that the standard use of a self-expanding stent graft for the management of ASARVI is feasible and

82 ed about the long-term performance of aortic stent grafts for the treatment of abdominal aortic aneur

83 dministration has approved four endovascular stent grafts for the treatment of abdominal aortic aneur

84 , W.L. Gore and Associates, Flagstaff, Ariz) stent-graft for direct intrahepatic portacaval shunt (DI

85 y useful in the construction of endovascular stent-grafts for use in human arteries.

86 Three patients underwent additional aortic stent grafting, four patients underwent placement of an

87 A Viatorr((R)) stent-graft (Gore, Flagstaff, AR, USA) is an endoprosthe

88 in the balloon-angioplasty group than in the stent-graft group (78% vs. 28%, P<0.001).

89 atment area was significantly greater in the stent-graft group than in the balloon-angioplasty group

90 at 6 months was significantly greater in the stent-graft group than in the balloon-angioplasty group

91 ative analysis of the several of the various stent grafts has been performed.

92 the advent of endovascular therapies such as stent-grafting has broadened the base of practitioners c

93 fter successful treatment using endovascular stent graft implantation.

94 isk of recurrence due to endoleaks following stent graft implantation.

95 per patient, necessity of additional aortic stent-graft implantation and/or placement of a bare meta

96 Angio-CT followed by stent-graft implantation over a short time interval (wit

97 t a giant celiac pseudoaneurysm treated with stent-graft implantation.

98 The points were connected, and a covered stent graft implanted to bypass the proximal vessel.

99 Routine use of a self-expanding nitinol stent graft in selected patients experiencing ASARVI aft

100 to the higher neo-bifurcation of the aortic stent graft in the type III as compared to the type V re

101 ation utilized closure devices alone in 61%, stent grafts in 17%, balloon tamponade facilitated closu

102 inical effectiveness of the Medtronic AneuRx stent-graft in patients with infrarenal abdominal aortic

103 asis in six (10%), mural thrombus within the stent-graft in two (3%), and new aortic dissection in on

104 rs after elective TEVAR were associated with stent graft induced false lumen thrombosis in 90.6% of c

105 spring stent grafts with direct evidence of stent graft-induced injury at surgery or necropsy in hal

106 Stent graft-induced new entry tear (SINE) is a serious c

107 is useful in the treatment of patients after stent-graft insertion for the management of descending t

108 neurysm was 58.8 mm before and 60.0 mm after stent-graft insertion.

109 bypass grafting and completion endovascular stent grafting is a feasible alternative to conventional

110 Endovascular stent grafting is performed in patients with aneurysms o

111 This PTFE-encapsulated stent-graft is biocompatible and safe to place.

112 main drawbacks of the use of e-PTFE covered stent-graft is higher incidence of hepatic encephalopath

113 aortic occlusion and placement of the aortic stent-graft is mandatory.

114 Placement of a fully supported stent-graft is necessary to repair an aortoiliac aneurys

115 ment of carotid pseudoaneurysms with covered stent-grafts is a safe and efficient method providing de

116 Transluminal placement of endovascular stent-grafts is a technically feasible method for treatm

117 Causes of rAAD included the stent graft itself (60%), manipulation of guide wires/sh

118 in aortic dissection patients caused by the stent-graft itself after thoracic endovascular aortic re

119 from the vessel wall most accurately enabled stent-graft length prediction for 31 AneuRx and two Excl

120 Endoleaks represent blood flow outside the stent-graft lumen but within the aneurysm sac.

121 Type I collagen as a intravascular stent-graft material is biocompatible for at least 3 mon

122 Patients undergoing endovascular stent grafting may benefit from risk stratification with

123 Surgeon-modified fenestrated stent grafts may be a viable option for selected high-su

124 stances of pulmonary failure, renal failure, stent-graft migration, or late leakage.

125 ched EVAR (n=8), and visceral deviation with stent grafting (n=7); no deaths occurred intraoperativel

126 Either a prototype stent-graft (n = 6) or Wallgraft (n = 2) was used to cre

127 patients who underwent de novo placement of stent-grafts (n = 10) was compared with that of patients

128 Endovascular stent grafting of aneurismal disease processes of the th

129 five patients after placement of additional stent-grafts or coil embolization to treat perigraft lea

130 Placement of a stent-graft over the entry tear was the most effective m

131 10) was compared with that of patients with stent-grafts placed during shunt revision (n = 6); in al

132 t placement was 90% +/- 9, whereas that with stent-grafts placed during TIPS revision was 17% +/- 15

133 Two patients had undergone stent graft placement and had short, wide tracts.

134 ic dilation was not observed at 1 year after stent graft placement within AADs with patent side branc

135 After stent graft placement, the stent struts and the graft we

136 not form in the AAD until immediately after stent graft placement; flow arrest occurred in the space

137 Stent-graft placement and thrombosis of the aneurysmal s

138 Primary unassisted patency rates following stent-graft placement at 4, 12, and 24 months (+/- stand

139 Endovascular stent-graft placement for the treatment of CBS in patien

140 After stent-graft placement in the 63 patients, CT demonstrate

141 y, safety, and effectiveness of transluminal stent-graft placement over the entry tear in 4 patients

142 In six cases, prior to stent-graft placement persistent biliary-TIPS fistulas w

143 cations of its management using endovascular stent-graft placement remain unclear due to limited publ

144 CBS can be safely managed with endovascular stent-graft placement that preserves carotid patency; ho

145 ths, primary unassisted patency with de novo stent-graft placement was 90% +/- 9, whereas that with s

146 ents with thoracic aortic aneurysm underwent stent-graft placement.

147 ent such as a carotid occlusion procedure or stent-graft placement.

148 ocedural and postprocedural complications of stent-graft placement.

149 The first 25,000 stent-graft procedures have been attended by significant

150 during the same hospital stay of the primary stent-graft procedures was identified.

151 In all, 67 CBS-related stent-graft procedures were performed in 62 patients (me

152 The use of endovascular stent-graft prosthesis for the treatment of AAAs is rece

153 All stent-grafts remained patent without increased aneurysma

154 Two years prior, the patient had undergone a stent graft repair of the thoracic aorta at the local va

155 mplication of open surgical and endovascular stent graft repair of thoracic and thoracoabdominal aort

156 early total and type 2 endoleak rates after stent-graft repair of AAAs; thus, patent sac branches pl

157 s more stable than conventional endovascular stent graft repairs, post-implantation movement of the e

158 Preliminary evidence suggests that stent grafts represent an important noninvasive option.

159 cant advances have also occurred recently in stent graft research and development.

160 itor blood leakage, without compromising the stent graft's function.

161 Transrenal fixation of aortic stent-grafts seems to be a relatively safe alternative c

162 These findings suggest that stent grafts should be used only in specific clinical sc

163 toiliac endovascular stent-grafts to correct stent-graft stenosis and preserve long-term function.

164 any aortic pathologies including trauma, but stent-grafts stiffen the aorta and likely increase LV af

165 The introduction of endovascular stent graft technology has ushered in a new era in thera

166 uminal exclusion of blood flow effected with stent graft technology.

167 Recent innovations in thoracic stent-graft technology have facilitated methods of repla

168 porary patients treated with just a standard stent graft that costs were significantly lower in 21 Ou

169 gen deposition within the interstices of the stent-graft that did not narrow the lumen of the stent-g

170 nly studies on transrenal fixation of aortic stent-grafts that included follow-up results for renal f

171 oup treated with contemporary unibody aortic stent grafts, the cumulative incidence of the primary en

172 For type B AAD, stent graft therapy (thoracic endovascular aortic repair

173 Stent graft therapy for aortic aneurysms is a valuable a

174 number of angiograms required to deploy the stent graft, thereby reducing delays.

175 e introduction of a dedicated e-PTFE covered stent-graft, these problems were completely solved, No m

176 One patient developed stent-graft thrombosis; the prior biliary-TIPS fistula w

177 In selecting the specific stent graft to be used for endovascular abdominal aortic

178 Previous studies used covered stent grafts to treat abdominal aortic aneurysms; howeve

179 Larger series of fenestrated stent grafts to treat juxtarenal aneurysms have been pub

180 e required in 31% of aortoiliac endovascular stent-grafts to correct stent-graft stenosis and preserv

181 e, and highlights the recent developments in stent graft treatment of abdominal aortic aneurysms.

182 dy of renal function before and after aortic stent-graft treatment was performed.

183 planar capacitive sensor was attached to the stent graft using a specially developed flexible thermal

184 in man implant of a three-vessel arch branch stent graft using a total percutaneous approach without

185 test the effect of closing the entry tear, a stent-graft was deployed over the entry tear under physi

186 At 1 month, the stent-graft was endothelialized and was infiltrated with

187 The portion of the aorta containing the stent-graft was excised and was histologically evaluated

188 re favorable outcomes were observed when the stent-graft was placed during de novo TIPS creation and

189 DIPS creation with the nitinol PTFE-covered stent-graft was superior to that after TIPS with the nit

190 up to 3 (total length 40 [35-45] mm) covered stent grafts were delivered to bypass the proximal vesse

191 Patients receiving stent grafts were more often female (62.2 versus 45.6%,

192 ic arteries followed by aortic relining with stent grafts were reviewed and tabulated.

193 Stent grafts were successfully implanted in 116 (95%) in

194 nal (n = 46) aortic aneurysms treated with a stent-graft were prospectively included.

195 Stent-grafts were constructed from modified Z-stents cov

196 nneled between both flank access points, and stent-grafts were deployed from each of the renal origin

197 Stent-grafts were dilated up to 14 mm (iliac) and 24 mm

198 Stent-grafts were implanted in a group of 18 dogs with a

199 Aortouniiliac stent-grafts were inserted in 42 patients and aortoaorti

200 Stent-grafts were inserted through surgically exposed fe

201 The stent-grafts were made of self-expanding stainless-steel

202 All stent-grafts were patent at all time points.

203 served among patients in whom Dacron-covered stent-grafts were placed during revision or de novo crea

204 Stent-grafts were placed successfully in all cases.

205 ing shunt revision (n = 6); in all patients, stent-grafts were placed within stents.

206 The stent-grafts were readily deployed in all cases.

207 All stent-grafts were successfully deployed, and endoleaks w

208 Stent-grafts were successfully placed in all 11 cases.

209 ialysis graft was improved with the use of a stent graft, which appears to provide longer-term and su

210 f a physician-modified external iliac artery stent graft with a side branch extension to facilitate s

211 This underscores the potential for stent graft with side branch extension as an option for

212 ociated with the use of proximal bare spring stent grafts with direct evidence of stent graft-induced

213 Stent grafts with proximal bare springs were used in maj

214 inferiority compared with non-unibody aortic stent grafts with respect to aortic reintervention, rupt

215 grafts are noninferior to non-unibody aortic stent grafts with respect to the composite primary outco

216 A composite nitinol-collagen endovascular stent-graft with a 4-mm inner diameter was deployed in t